Citadel Advisors’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.38B Sell
8,785,300
-833,200
-9% -$248M 0.38% 40
2025
Q4
$3.18B Sell
9,618,500
-1,362,900
-12% -$462M 0.48% 34
2025
Q3
$3.79B Buy
10,981,400
+3,917,000
+55% +$1.18B 0.58% 24
2025
Q2
$2.2B Buy
7,064,400
+5,089,600
+258% +$1.95B 0.38% 34
2025
Q1
$1.03B Buy
1,974,800
+191,100
+11% +$97.7M 0.2% 52
2024
Q4
$902M Buy
1,783,700
+179,500
+11% +$102M 0.16% 66
2024
Q3
$938M Buy
1,604,200
+153,000
+11% +$86.5M 0.18% 63
2024
Q2
$739M Sell
1,451,200
-32,000
-2% -$15.7M 0.15% 83
2024
Q1
$734M Sell
1,483,200
-96,500
-6% -$49.1M 0.14% 81
2023
Q4
$832M Sell
1,579,700
-74,500
-5% -$39.7M 0.17% 60
2023
Q3
$834M Buy
1,654,200
+89,600
+6% +$44.1M 0.18% 50
2023
Q2
$752M Buy
1,564,600
+53,100
+4% +$26M 0.16% 57
2023
Q1
$714M Sell
1,511,500
-59,600
-4% -$28.8M 0.16% 62
2022
Q4
$833M Sell
1,571,100
-734,500
-32% -$389M 0.19% 53
2022
Q3
$1.16B Buy
2,305,600
+524,000
+29% +$276M 0.27% 31
2022
Q2
$915M Buy
1,781,600
+684,800
+62% +$344M 0.23% 37
2022
Q1
$559M Buy
1,096,800
+325,000
+42% +$157M 0.12% 93
2021
Q4
$388M Sell
771,800
-26,500
-3% -$12M 0.08% 157
2021
Q3
$312M Buy
798,300
+284,200
+55% +$118M 0.06% 205
2021
Q2
$206M Buy
514,100
+36,800
+8% +$14.7M 0.05% 302
2021
Q1
$178M Buy
477,300
+53,600
+13% +$18.6M 0.04% 332
2020
Q4
$149M Sell
423,700
-239,400
-36% -$80.2M 0.04% 368
2020
Q3
$207M Sell
663,100
-76,400
-10% -$23.5M 0.06% 192
2020
Q2
$218M Sell
739,500
-78,500
-10% -$22.5M 0.08% 159
2020
Q1
$204M Sell
818,000
-123,800
-13% -$34.1M 0.09% 134
2019
Q4
$277M Buy
941,800
+55,800
+6% +$14.6M 0.12% 113
2019
Q3
$193M Buy
886,000
+267,500
+43% +$64.5M 0.09% 165
2019
Q2
$151M Buy
618,500
+218,400
+55% +$52.5M 0.07% 240
2019
Q1
$98.9M Sell
400,100
-6,700
-2% -$1.71M 0.05% 367
2018
Q4
$101M Sell
406,800
-245,500
-38% -$64.9M 0.06% 319
2018
Q3
$174M Buy
652,300
+24,100
+4% +$6.27M 0.08% 217
2018
Q2
$154M Buy
628,200
+368,300
+142% +$88.4M 0.08% 230
2018
Q1
$55.6M Buy
259,900
+15,200
+6% +$3.47M 0.03% 550
2017
Q4
$53.9M Buy
244,700
+5,800
+2% +$1.23M 0.03% 578
2017
Q3
$46.8M Sell
238,900
-33,600
-12% -$6.49M 0.04% 583
2017
Q2
$50.5M Buy
272,500
+14,900
+6% +$2.61M 0.04% 489
2017
Q1
$42.2M Sell
257,600
-62,800
-20% -$10.3M 0.04% 526
2016
Q4
$51.3M Buy
320,400
+60,700
+23% +$9.07M 0.05% 376
2016
Q3
$36.4M Sell
259,700
-32,400
-11% -$4.54M 0.04% 538
2016
Q2
$41.2M Buy
292,100
+11,000
+4% +$1.47M 0.05% 425
2016
Q1
$36.2M Buy
281,100
+38,400
+16% +$4.54M 0.05% 429
2015
Q4
$28.6M Sell
242,700
-81,600
-25% -$9.54M 0.03% 638
2015
Q3
$37.6M Buy
324,300
+28,300
+10% +$3.39M 0.04% 556
2015
Q2
$36.1M Buy
296,000
+58,800
+25% +$6.96M 0.03% 649
2015
Q1
$28.1M Buy
237,200
+36,300
+18% +$4.03M 0.03% 785
2014
Q4
$20.3M Buy
200,900
+18,700
+10% +$1.77M 0.02% 936
2014
Q3
$15.7M Buy
182,200
+46,000
+34% +$3.89M 0.02% 1054
2014
Q2
$11.1M Sell
136,200
-195,000
-59% -$15.3M 0.01% 1186
2014
Q1
$27.2M Sell
331,200
-79,500
-19% -$5.98M 0.03% 655
2013
Q4
$30.9M Buy
410,700
+244,600
+147% +$17.6M 0.04% 576
2013
Q3
$11.9M Sell
166,100
-22,900
-12% -$1.64M 0.02% 1002
2013
Q2
$12.4M Buy
+189,000
New +$11.8M 0.02% 925

Other funds holding UNH

Citadel Advisors's UNH Position: Q1 2026 in Review

Citadel Advisors reduced its UnitedHealth (UNH) stake by 47% in Q1 2026, selling an estimated $413M and leaving 1,542,330 shares worth $417M. The position accounts for 0.07% of the portfolio, ranked #219.

Citadel Advisors first reported a position in UNH in Q2 2013 and has held it in 49 quarters since. The position peaked at $967M in Q4 2025. 3,020 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

  • Citadel Advisors held 1,542,330 shares of UnitedHealth worth $417M as of Q1 2026.
  • Citadel Advisors sold 1,386,011 UnitedHealth shares in Q1 2026, an estimated $413M.
  • UnitedHealth made up 0.07% of Citadel Advisors's portfolio in Q1 2026, its #219 holding.
  • Citadel Advisors first reported a position in UnitedHealth in Q2 2013 and has held it in 49 quarters since.
  • Citadel Advisors's UnitedHealth position peaked at $967M in Q4 2025.
  • 3,020 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.